Protalix BioTherapeutics PLX
NYSE PLX
$2.54 -0.03 (-1.12%)
As of: Oct 23, 2026 · 3:59 PM EDT

Protalix BioTherapeutics (PLX) Income from Discontinued Operations (2015 - 2016)

Updated

Protalix BioTherapeutics' Income from Discontinued Operations was -$189,000 in FY2016, compared with $85.32 million in FY2015.

Analysis

Protalix BioTherapeutics (PLX) Income from Discontinued Operations (2015 - 2016) Analysis & Trends

From FY2013 onward, Protalix BioTherapeutics has reported Income from Discontinued Operations for 4 years.

  • Per Business Quant data, Income from Discontinued Operations in earlier years was $85.32 million in FY2015, $3.36 million in FY2014 (-51.7%) and $6.95 million in FY2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn -
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn -
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn -
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn -
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn -
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 8.00 Mn
10 Protalix BioTherapeutics 204.37 Mn 52.98 Mn 12.13 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2016 -117,000.00
Mar 31, 2016 -72,000.00
Dec 31, 2015 81.47 Mn
Sep 30, 2015 2.20 Mn
Jun 30, 2015 1.11 Mn
Mar 31, 2015 541,000.00
API Access

Protalix BioTherapeutics Income from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=PLX&period=max&api_key=YOUR_API_KEY